Vaccines for the New Millennium Act of 2005

Bill: 109-s-1698
Sponsor: Sen. Kerry, John F. [D-MA]
Introduced: 2005-09-14 in the Senate
Policy area: Health
Subjects: AIDS (Disease)
Child health
Clinical trials
Commerce
Communicable diseases
Competition
Congress
Congressional reporting requirements
Contracts
Corporation taxes
Developing countries
Development credit institutions
Dispute settlement
Drug approvals
Drug industry
Drugs
Economics and Public Finance
Families
Foreign Trade and International Finance
Gifts
Government Operations and Politics
Government contractors
Government procurement
Government trust funds
Governmental investigations
Human immunodeficiency viruses
Income tax
Intellectual property
International Affairs
International agencies
International cooperation in science
Law
Liability (Law)
Malaria
Medical malpractice
Medical technology
Negotiations
Nongovernmental organizations
Nonprofit organizations
Patents
Pharmaceutical research
Preventive medicine
Prices
Public-private partnerships
Research and development
Research and development tax credit
Research grants
Science, Technology, Communications
Small business
Social Welfare
Tax credits
Tax refunds
Taxation
Technology transfer
Treaties
Tuberculosis
United Nations
Vaccination
Vaccines
World health

Summary:
action_date: 2005-09-14
text: 
Vaccines for the New Millennium Act of 2005 - Directs the President to establish a strategy to accelerate efforts to develop vaccines and microbicides for neglected diseases such as HIV/AIDS, malaria, and tuberculosis, which shall: (1) expand public-private partnerships; (2) create economic incentives for such vaccines' research, development, and manufacturing; (3) include the negotiation of advanced market commitments; (4) address related intellectual property and regulatory approval issues; (5) maximize U.S. capabilities to support clinical trials in developing countries; (6) expand the purchase and delivery of existing vaccines; and (7) address the challenges of advance delivery of vaccines in developing countries. 
 
Directs the Secretary of the Treasury to: (1) enter into negotiations with the World Bank, the International Development Association, Global Alliance for Vaccines and Immunizations, and other interested parties to establish advanced market commitments to purchase such vaccines and microbicides; and (2) establish in the Treasury the Lifesaving Vaccine Purchase Fund.
 
Amends the Internal Revenue Code to establish business credits for: (1) vaccine research related to HIV/AIDS, malaria, tuberculosis, or certain infectious diseases afflicting developing countries; and (2) certain sales of lifesaving vaccines to nonprofit organizations, or to foreign governments or instrumentalities for distribution in developing countries.
 
Amends the Small Business Act to: (1) direct the Small Business Administration (SBA) to establish a four-year pilot program to encourage the development of such vaccines and microbicides, including program outreach activities; and (2) provide Small Business Innovation Research Program (SBIR) and Small Business Technology Transfer Program (STTR) funding for such vaccines and microbicides.
 


Legislative actions:
action_date: 2005-09-14
text: Read twice and referred to the Committee on Finance. (text of measure as introduced: CR S10040-10043)
action_date: 2005-09-14
text: Sponsor introductory remarks on measure. (CR S10039-10040)
action_date: 2005-09-14
text: Introduced in Senate